Why I’d ditch buy-to-let property and buy these 2 bargain FTSE 100 shares right now

These two FTSE 100 (INDEXFTSE:UKX) shares could offer higher return potential than a buy-to-let investment in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The prospects for buy-to-let investors continue to be highly challenging. Stamp duty increases, changes to mortgage interest relief and weak house price growth are just a few of the difficulties they face that could lead to lower returns in the long run.

As such, now could be the right time to consider gaining exposure to the property market through shares, rather than a buy-to-let. After all, a number of FTSE 100 housebuilders currently trade on low valuations which suggest they offer good value for money.

With that in mind, here are two large-cap shares that could provide impressive return prospects. While not without risk, their investment appeal as part of a wider portfolio of stocks could be significantly higher than a buy-to-let property at the present time.

Barratt

Recent updates from Barratt (LSE: BDEV) have helped to reassure investors that the housebuilder is delivering an impressive financial performance despite weakness in the wider property market. Government policies such as Help to Buy and stamp duty relief for first-time buyers are helping to catalyse the wider industry and provide resilient demand for the company’s properties.

Looking ahead, Barratt is forecast to record a 1% decline in its bottom line in the current year. However, its financial performance is largely dependent on political developments. Should they prove to be favourable in the eyes of investors, its price-to-earnings (P/E) ratio of 8.8 suggests there is significant room for capital growth.

In the long run, the company may stand to benefit from a lack of supply and increasing demand for its homes. Due to it being well-run, in terms of having a solid balance sheet and a large supply of land, its long-term prospects could be relatively bright.

Berkeley

Another FTSE 100 housebuilder that could be a strong performer over the coming years is Berkeley (LSE: BKG). The housebuilder’s focus on London may have counted against it in recent years, with the capital’s property market underperforming many other UK regions as uncertainty regarding Brexit has been relatively high. However, London’s historic house price performance suggests that it could offer long-term growth.

Berkeley’s P/E ratio of 13.4 continues to offer good value for money even after its recent share price spike. The company’s strategy that focuses on long-term projects which may provide greater stability and higher returns versus sector peers could lead to impressive capital growth for its investors. It also has a generous capital return programme that could produce a dividend yield of up to 4% per annum over the medium term.

Certainly, the stock could experience a period of volatility in the short run if political risks continue to be high. But as a cyclical stock, now could be the right time to buy a slice of it while it offers a wide margin of safety.

Peter Stephens owns shares of Barratt Developments and Berkeley Group Holdings. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »